BCG vaccine may rewire brain immunity, shift Alzheimer's markers over 12 months. New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) vaccine—which is delivered through the skin to prevent tuberculosis—may remodel the human brain's immune environment, offering a potential biological explanation for previously observed associations between BCG vaccination and lower Alzheimer's disease risk.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) vaccine—which is delivered through the skin to prevent tuberculosis—may remodel the human brain's immune environment, offering a potential biological explanation for previously observed associations between BCG vaccination and lower Alzheimer's disease risk. Findings are published in Communications Medicine.
- Ponto de atenção: vaccine.
- Ponto de atenção: rewire.
- Ponto de atenção: brain.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.